loading...
Developing a Traceable Domain Reference Architecture to Support Clinical Trials at the National Cancer Institute - An Experience Report
Washington DC April 17-April 20
DOI Bookmark: http://doi.ieeecomputersociety.org/10.1109/ECBS.2001.922416Eighth Annual IEEE International Conf ...
 This Article 
 
PDF
HTML
 
 Share 
   
 Bibliographic References 
   
 Add to: 
 
Digg
Furl
Spurl
Blink
Simpy
Google
Del.icio.us
Y!MyWeb
 
 Search 
   
K.S. Barber, The University of Texas at Austin
T. Graser, The University of Texas at Austin
J. Silva, National Cancer Institute
Abstract: This paper presents the requirements gathering and software architecture derivation approach developed by the University of Texas at Austin and leveraged by the National Cancer Institute (NCI) in their efforts to automate the creation, management, and evaluation of clinical trials. NCI must face the complexity of managing clinical trials and coordinating large numbers and varied types of stakeholders. The Systems Engineering Process Activities (SEPA) from the University of Texas at Austin is well suited to address domain modeling and software development at NCI due to a strong emphasis on explicit traceability from a derived architecture to individual Knowledge Acquisition (KA) sessions as well as facilitated resolution among conflicting stakeholder contributions. Specifically, this paper focuses on the SEPA Domain Reference Architecture (DRA), a software architecture designed to capture domain requirements (i.e., domain data, functionality, and timing).
Citation:
K.S. Barber, T. Graser, J. Silva, "Developing a Traceable Domain Reference Architecture to Support Clinical Trials at the National Cancer Institute - An Experience Report," ecbs, pp.0144, Eighth Annual IEEE International Conference and Workshop on the Engineering of Computer Based Systems (ECBS '01), 2001
Usage of this product signifies your acceptance of the Terms of Use.